Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-04
2009-12-29
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S407000
Reexamination Certificate
active
07638548
ABSTRACT:
There are provided compounds of the general formulaswherein X, Y, R1, R2, R3and R4are as described herein. The compounds exhibit anticancer activity.
REFERENCES:
patent: 6573386 (2003-06-01), Gonczi et al.
patent: 0 947 511 (1999-10-01), None
Hans-Dieter Arndt, pp. 4664-4673, Angewandte Chemie, 2006, 118.
Liu Jin-Jun
Zhang Zhuming
Anderson Rebecca L
Hoffmann-La Roche Inc.
Johnston George W.
Nolan Jason
Rocha-Tramaloni Patricia S.
LandOfFree
Spiroindolinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiroindolinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiroindolinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4113976